Is Cannabis a Proven Treatment for Generalised Anxiety Disorder (GAD)?

PostedFebruary 24, 2026

UpdatedFebruary 24, 2026

ByMy Patient Advice

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Generalised Anxiety Disorder (GAD) affects millions, causing persistent worry, restlessness, and physical symptoms such as tension and fatigue. Emerging research into cannabis as GAD treatment suggests potential benefits, though evidence is still developing. Patients and clinicians are exploring how cannabinoids may support symptom management and improve overall patient outcomes.

Evaluating Cannabis for GAD

Studies and clinical observations offer insights into the effects of cannabis as GAD treatment, highlighting both promise and limitations.

Symptom Relief

Cannabinoids like CBD may reduce anxiety symptoms, promoting calmness and enhancing overall wellbeing in cases of generalised anxiety.

Mood Regulation

Cannabis can influence the endocannabinoid system, potentially helping stabilise mood and lower stress levels.

Personalised Therapy

Tailored dosing and cannabinoid ratios allow clinicians to customise cannabis as GAD treatment, optimising benefits while minimising side effects.

Supporting Clinical Research

Ongoing clinical research is essential to validate effectiveness, safety, and long-term impacts on patients with GAD.

While cannabis as GAD treatment is not yet universally accepted or fully proven, early evidence indicates it could be a valuable tool for patients who have not responded adequately to conventional therapies. By combining careful monitoring, personalised dosing, and insights from clinical research, cannabis may offer meaningful support for managing generalised anxiety and improving patient outcomes.

If you’re exploring cannabis treatment options for anxiety disorders, visit providers like LeafEase for personalised consultations and guidance tailored to your needs.

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and anxiety disorders.

Julia Sutton, MSc

Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Dr. Clarissa Morton, PharmD

Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy.